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Crystallization and diffraction data of 1H-3-hydroxy-4-oxoquinoline
2,4-dioxygenase: a cofactor-free oxygenase of the alpha/beta-hydrolase family
Abstract
1H-3-Hydroxy-4-oxoquinoline 2,4-dioxygenase (QDO) from Pseudomonas putida 33/1 catalyses the
oxygenolysis of 1H-3-hydroxy-4-oxoquinoline to form N-formylanthranilic acid and carbon monoxide
without the aid of cofactors. Both N-terminally His6-tagged and native QDO were overexpressed in
Escherichia coli and purified by conventional chromatographic procedures. Untagged QDO, but not
His6-tagged QDO, was crystallized by the vapour-diffusion method, giving hexagonal bipyramid crystals
belonging to space group P6(1)22. Selenomethionine-containing native QDO was prepared and
crystallized under identical conditions. The unit-cell parameters were a = b = 90.1, c = 168.6 A, alpha =
beta = 90, gamma = 120 degrees. Using synchrotron radiation, these crystals diffract to 2.5 A. The
expression, purification and crystallization of QDO are reported here.
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Crystallization and diffraction data of
1H-3-hydroxy-4-oxoquinoline 2,4-dioxygenase: a
cofactor-free oxygenase of the a/b-hydrolase family
1H-3-Hydroxy-4-oxoquinoline 2,4-dioxygenase (QDO) from Pseudomonas
putida 33/1 catalyses the oxygenolysis of 1H-3-hydroxy-4-oxoquinoline to form
N-formylanthranilic acid and carbon monoxide without the aid of cofactors.
Both N-terminally His6-tagged and native QDO were overexpressed in
Escherichia coli and purified by conventional chromatographic procedures.
Untagged QDO, but not His6-tagged QDO, was crystallized by the vapourdiffusion method, giving hexagonal bipyramid crystals belonging to space group
P6122. Selenomethionine-containing native QDO was prepared and crystallized
under identical conditions. The unit-cell parameters were a = b = 90.1,
c = 168.6 Å,  =  = 90,  = 120 . Using synchrotron radiation, these crystals
diffract to 2.5 Å. The expression, purification and crystallization of QDO are
reported here.
1. Introduction
Monooxygenases and dioxygenases catalyse the incorporation of
oxygen into organic compounds in several aerobic metabolic pathways. 1H-4-Oxoquinoline is degraded by Pseudomonas putida 33/1
via the anthranilate pathway. An intermediate step in this pathway is
the ring oxygenolysis of 1H-3-hydroxy-4-oxoquinoline to form
carbon monoxide and N-formylanthranilate. This step is catalysed by
1H-3-hydroxy-4-oxoquinoline 2,4-dioxygenase (QDO; EC 1.13.11.47).
Arthrobacter nitroguajacolicus Rü61a (formerly A. ilicis Rü61a)
possesses an enzyme, 1H-3-hydroxy-4-oxoquinaldine 2,4-dioxygenase
(HOD; EC 1.13.11.48; Fischer et al., 1999), that catalyzes an analogous reaction (Fig. 1).
Most oxygenases contain metal ions (usually copper or iron) or
flavins to activate oxygen. QDO and HOD have no requirement for
such cofactors (Fetzner, 2002). Kinetic analysis of HOD indicates that
the enzyme operates by a compulsory-order ternary-complex
mechanism, with binding of the heterocyclic substrate preceding that
of oxygen (Frerichs-Deeken et al., 2004).
QDO is a 264-amino-acid protein of molecular weight 30 kDa.
Analysis of the amino-acid sequence of QDO indicates that it is a
member of the /-hydrolase superfamily of enzymes (Fischer et al.,
1999). The canonical fold has a central -sheet with strand 2 antiparallel to the rest. The connection of strand order is +1, +2, 1x,
+2x, +1x, +1x (Heikinheimo et al., 1999). These enzymes contain a
catalytic triad consisting of a nucleophile, a histidine and an acidic
residue. The nucleophile can be a serine, cysteine or aspartate
residue. In QDO, the catalytic histidine has been identified (Fischer &
Fetzner, 2000). Site-directed mutagenesis of QDO indicates that this
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The reactions catalysed by QDO (R = H) and HOD (R = CH3). The substrates
are 1H-3-hydroxy-4-oxoquinoline (R = H) and 1H-3-hydroxy-4-oxoquinaldine
(R = CH3).
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Table 1
Crystallographic parameters and Se-MAD data-collection statistics.
Values in parentheses are for the highest resolution bin.
Protein

SeMet

SeMet

Space group
Unit-cell parameters
(Å, )
Wavelength (Å)
Resolution (Å)
hI/(I)i
Rsym† (%)
Completeness (%)
Unique reflections
Average redundancy

P6122
P6122
a = b = 90.1, c = 168.6,
 =  = 90.0,  = 120.0
0.97929 (peak)
0.98220 (inflection)
50.0–2.7 (2.8–2.7) 50–2.7 (2.8–2.7)
24.2 (2.1)
34.2 (3.2)
5.1 (33.9)
6.2 (36.3)
99.2 (92.3)
99.7 (97.3)
20929 (1933)
21039 (2038)
3.8 (3.1)
7.5 (6.2)

Native
P6122
a = b = 90.2, c = 168.9,
 =  = 90.0,  = 120.0
0.97929
50–2.5 (2.59–2.5)
23.1 (2.89)
9.4 (43.5)
98.8 (98.2)
25905 (2324)
9.3 (5.4)

P P
P P
† Rsym = hkl i jIhkl;i  hIhkl ij= hkl i Ihkl;i , where hIhkli is the mean intensity of a set
of equivalent reflections and Ihkl,i is the ith measurement of the reflection with Miller
indices hkl.

residue is absolutely required for catalytic activity (Fischer & Fetzner,
2000).
In order to understand the catalytic mechanism of QDO, we have
undertaken to solve the structure of this enzyme. Here, we report the
expression, purification, crystallization and preliminary diffraction
data for QDO. The crystallization of HOD is described in the
accompanying paper (Steiner et al., 2007).

2. Materials and methods
2.1. Cloning, expression and protein purification

The QDO gene was obtained in vector pQE50-QDO (Fischer &
Fetzner, 2000). Initial attempts to express the protein in this vector
were unsuccessful. We therefore set about cloning the gene into new
vectors for protein expression. The QDO gene was PCR-amplified
with Turbo Pfu Taq polymerase (Stratagene) using the primer set
RSC968 d(AACTATGAGAGGACATATGCATTCG) and RSC979
d(ATTAACCATGGCTGCAGGTCGACCAG) and pQE50-QDO as
the template. The PCR product was digested with restriction enzymes
NdeI and NcoI and cloned into linearized vectors pRSC722 (for
untagged QDO) and pRSC774 (N-terminally His6-tagged QDO),
respectively. The tagged protein contained only an N-terminal
methionine residue plus six histidine residues. Selection was made in
Luria–Bertani (LB) medium supplemented with ampicillin
(100 mg ml1). Recombinant plasmid DNA was prepared with a
QIAprep Spin Miniprep kit (Qiagen).
Escherichia coli strain BL21(DE3)recA was used to express QDO
in all cases. Cells harbouring pRSC774-QDO or pRSC722-QDO were
cultured for 12 h in LB medium supplemented with 100 mg ml1
ampicillin. Stationary phase culture (2 ml) was transferred into
200 ml LB media and incubated for 7 h at 310 K with agitation at
200 rev min1. Overexpression of QDO was achieved by sixfold
dilution of the culture in the same medium supplemented with
100 mg ml1 ampicillin and 0.5 mM (final concentration) isopropyl
-d-thiogalactopyranoside (IPTG) and overnight culture at room
temperature in a water bath with 200 rev min1 agitation. The culture
was then centrifuged at 8000 rev min1 in an SLA 3000 rotor
(Sorvall) and the cells were resuspended in 20 mM sodium phosphate
buffer pH 7.5 for N-terminal His6-tagged QDO cells or in 50 mM Tris
pH 7.6 for non-His-tagged QDO. The cells were lysed using a French
Press (SLM Instruments) at 4.9 MPa in the presence of 0.5 mM
phenylmethanesulfonyl fluoride (PMSF). Cell debris was removed by
centrifugation at 15 000 rev min1 using an SS34 rotor (Sorvall).
Acta Cryst. (2007). F63, 378–381

His6-tagged QDO was purified using a 5 ml prepacked HiTrap
chelating column (Amersham) charged with Ni2+ connected to an
Äkta liquid-chromatography system (Pharmacia). The cell lysate was
loaded onto the prepacked 5 ml Ni–NTA column pre-equilibrated
with buffer containing 20 mM sodium phosphate, 0.5 M sodium
chloride pH 7.4, followed by washing with five column volumes of the
same buffer. Bound recombinant His6-tagged QDO was eluted with a
0–250 mM imidazole gradient in 20 mM sodium phosphate buffer
containing 0.5 M sodium chloride pH 7.4 at a flow rate of 1 ml min1.
Pure fractions were pooled, dialysed against 50 mM Tris buffer pH 7.6
to remove the imidazole and concentrated.
Nontagged QDO was purified using a DEAE Fractogel column
followed by a G75 gel-filtration column using an Äkta liquidchromatography system (Pharmacia). QDO was precipitated by the
addition of ammonium phosphate (0.25–0.50 g ml1). The precipitate
was centrifuged at 13 000 rev min1 for 30 min using an SS34 rotor.
The pellet was resuspended in 50 mM Tris pH 7.6 and dialysed against
the same buffer. Crude QDO fractions were obtained using a 0–
300 mM linear gradient of sodium chloride on a Toyopearl DEAE650M column (Tosoh) with the aid of an Äkta liquid-chromatography
system. This fraction was dialysed against two changes of 50 mM Tris
pH 7.6 in an at least 100-fold dilution volume and concentrated to less
than 3 ml using Amicon Ultra-15 centrifugal filter devices (10 000
NMWL, Millipore). Concentrated crude sample was loaded onto a
300 ml G-75 column (Pharmacia) and pure QDO was separated from
other proteins at a flow rate of 0.5 ml min1 over a 300 ml volume.
Protein purity was monitored by SDS–PAGE.
Selenomethionine labelling of the recombinant QDO protein was
conducted according to Van Duyne et al. (1993). 50 ml stationary
phase BL21(DE3)recA cells harbouring pRSC722-QDO plasmid
were spun down, washed once with MilliQ water and transferred to
1.0 l minimal medium containing 50 mM Na2HPO4, 50 mM KH2PO4,
25 mM (NH4)3PO4, 0.4% glucose, 2 mM MgSO4 plus 0.2% trace
elements. Amino acids supplemented per litre culture were as
follows: selenomethinine (50 mg), threonine (100 mg), phenylalanine
(100 mg), lysine (100 mg), leucine (50 mg), isoleucine (50 mg) and
valine (50 mg). The inoculated culture was incubated at 310 K with
200 rev min1 agitation until the OD595 reached 0.7. Induction of the
protein took place by the addition of 0.5 mM IPTG (final concentration) and culture at room temperature with 200 rev min1 shaking.
Labelled QDO was purified in an identical manner to native QDO as
described above.
2.2. Crystallization

Initially, a search for potential crystallization conditions was
conducted using the 96-solution Index Screen (Hampton Research).

Figure 2
Drops containing crystals of (a) native and (b) selenomethionine-labelled QDO.
The largest crystals in both cases are about 275 mm from tip to tip.
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Figure 3
Coomassie-stained SDS–PAGE gels showing (a) His6-tagged QDO eluted from nickel resin, (b) native and (c) selenomethionine QDO fractions eluted from a G75 column
(final step). Arrows indicate fractions pooled for the final concentration step prior to crystallization. M indicates the column containing molecular-weight markers. These are,
in descending order, 97, 66, 45 30 20.1 and 14.4 kDa.

Art Robinson IntelliPlates were used for sitting-drop vapourdiffusion experiments. Equal volumes (1 ml) of protein (15 mg ml1 in
50 mM Tris pH 7.6 in all cases) and crystallization reagents were
mixed and then allowed to equilibrate against the well solution
(100 ml) at 277 K. For optimization of crystallization conditions, the
hanging-drop technique in 24-well plates (Linbro) was used. Drops
containing 3 ml protein solution and 3 ml reservoir solution were
suspended on plastic cover slips above 1 ml reservoir solution.
2.3. X-ray diffraction

X-ray data were collected on beamline 19-ID at the Advanced
Photon Source. Multiple-wavelength anomalous dispersion (MAD)
data were collected using a Quantum-315 area detector (ADSC) for
native and selenomethionine QDO. A crystal-to-detector distance of
290 mm and an exposure time of 15 s per 0.25 frame were used in all
cases. Diffraction images were indexed, integrated and scaled using
the HKL-3000 package (Minor et al., 2006). Crystals were prepared
for freezing by transferring them into artificial mother liquor
containing increasing concentrations of sodium formate. At each
step, the sodium formate concentration was increased by 0.25 M and
the crystals were equilibrated in the solutions for 3 min each. The
maximum concentration of sodium formate used was 6 M. Crystals
were flash-cooled by transferring them into liquid nitrogen. All data
were collected at 100 K using an Oxford Cryostream. Data-collection
statistics are given in Table 1.

3. Results
His6-tagged QDO did not yield crystals under any of the conditions in
the Index Screen. Untagged native QDO gave crystals in conditions
Nos. 19 (0.056 M sodium dihydrogen phospate, 1.344 M dipotassium
hydrogen phosphate), 24 (2.8 M sodium acetate), 25 (3.5 M sodium
formate), 29 (60% Tacsimate pH 7.0) and 30 (0.1 M sodium chloride,
0.1 M bis-Tris pH 6.5, 1.5 M ammonium sulfate). The best crystals, as
judged by size and morphology, grew as hexagonal bipyramids from
condition No. 25 and appeared after 9 d. Optimization using the
hanging-drop vapour-diffusion technique resulted in good crystals
from 4.1–4.6 M sodium formate pH 7.8. Crystals appeared after 2 d
and grew to maximum size in one week. The largest crystals used for
X-ray data collection were about 275 mm long by 200 mm wide at the
equator (Fig. 2). Untagged selenomethionine-containing QDO gave
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crystals with a similar appearance under identical conditions (Fig. 2).
Initial phasing was based on three (out of a theoretical six) selenium
sites. The correct hand was indicated by a clear difference in contrast
between the original and inverted-hand enantiomorphs. Initial
electron-density maps revealed helices of the correct hand in a
protein that appears to adopt the predicted /-hydrolase topology.
The asymmetric unit appears to contain one monomer, giving a
Matthews coefficient of 3.25 Å3 Da1 and a solvent content of 62%
for the crystal.
It is noteworthy that the His6-labelled QDO did not crystallize in
screens, whereas untagged native and selenomethionine-derived
QDO did. Even when hanging-drop vapour-diffusion experiments
with His6-tagged QDO and sodium formate were performed under
identical conditions to those used for native QDO, no crystals
resulted. Since the purity of all the samples used in crystallization
experiments was close to 100% as judged by SDS–PAGE (Fig. 3) and
the final buffer composition for all protein samples subjected to
crystallization trials was identical, we propose that the His6 tag itself
directly interfered with crystallization. Such tags do not always
interfere with crystallization. The current release of the PDB
(Berman et al., 2007) contains 457 proteins with His tags solved by
protein crystallography. In a systematic study of the effect of tags on
the crystallization of Pyrococcus furiosus maltodextrin-binding
protein, His6-tagged protein produced crystals with similar crystallographic characteristics to the native protein (Bucher et al., 2002).
Conversely, the removal of a His tag was required for the formation
of high-quality crystals of phosphotransfer protein ZmHP1 from
maize (Sugawara et al., 2005).
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